Having already claimed the Outstanding Achievement prize at the Yorkshire & Humber Medilink Business Awards, Tissuemed head to The Ricoh Arena, Coventry this week for the National Healthcare Business Awards 2017.
For Tissuemed, David Mandley, CEO commented, “Our original award recognised Tissuemed’s achievement in obtaining Chinese regulatory approval (CFDA) for the TissuePatch™ Product Range. This is a notable and transformative approval that everyone at Tissuemed is naturally proud of. It’s an honour to be representing the region at this year’s annual Medilink Awards, and we look forward to joining the other finalists and delegates at the Med-Tech Innovation Expo to celebrate these achievements.”
For further information about Tissuemed’s innovative products and their applications across a range of surgical disciplines click here. To arrange an evaluation contact our sales team via firstname.lastname@example.org